Abstract
In Alzheimer's disease (AD) brain oxidative stress is observed indexed by several markers, among which are protein carbonyls and 3-nitrotyrosine, markers for protein oxidation. We hypothesized that identity of these oxidatively modified proteins would lead to greater understanding of some of the potential molecular mechanisms involved in neurodegeneration in this dementing disorder. Proteomics is an emerging method for identification of proteins, and its application to neurodegenerative disorders, especially AD, is just beginning. Posttranslational modification of brain proteins, particularly that due of oxidation of proteins, provides an effective means of screening a subset of proteins within the brain proteome that likely reflects the extensive oxidative stress under which the AD brain exists, and this new methodology provides insights into mechanisms of neurodegeneration in and new therapeutic targets for AD. In this review, the use of proteomics to identify specifically oxidized proteins in AD brain is presented, from which new insights into mechanisms of neurodegeneration and synapse loss in this dementing disorder that is associated with oxidative stress have emerged.
| Original language | English |
|---|---|
| Pages (from-to) | 1-7 |
| Number of pages | 7 |
| Journal | Brain Research |
| Volume | 1000 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - Mar 12 2004 |
Bibliographical note
Funding Information:This work was supported in part by NIH grants (AG-05119; AG-10836). The author thanks Ms. Mollie Fraim and Ms. Debra Boyd-Kimball for assistance in preparation of this manuscript.
Keywords
- Alzheimer's disease brain
- Degenerative disease: Alzheimer's beta-amyloid
- Disorders of the nervous system
- Oxidative stress
- Proteomics
ASJC Scopus subject areas
- General Neuroscience
- Molecular Biology
- Clinical Neurology
- Developmental Biology